Data-driven startup Zephyr AI has raised $18.5 million in seed funding to advance precision medicine and drug discovery with machine learning. The startup’s tech combines data from multiple sources, ...

Guardant Health (Nasdaq: GH), a leading precision oncology company, and Zephyr AI, a leader in precision medicine harnessing artificial intelligence to accelerate drug development, today announced a ...

Guardant Health and Zephyr AI have partnered to advance the discovery of novel cancer biomarkers, as more precise tumour ...

Oncology-focused biotech company Guardant Health is partnering with AI drug development company Zephyr AI to combine AI and machine learning technologies and multimodal molecular data to advance ...

PALO ALTO, Calif. & MCLEAN, Va.--(BUSINESS WIRE)--Guardant Health (Nasdaq: GH), a leading precision oncology company, and Zephyr AI, a leader in precision medicine harnessing artificial intelligence ...